BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6247651)

  • 1. The activity of ketoconazole in mixed cultures of fungi and human fibroblasts.
    Aerts F; De Brabander M; van den Bossche H; van Cutsem J; Borgers M
    Mykosen; 1980 Feb; 23(2):53-67. PubMed ID: 6247651
    [No Abstract]   [Full Text] [Related]  

  • 2. The activity of ketoconazole in clinical isolates of candida albicans cultured in a mycelium promoting medium.
    Van Cutsem J; Borgers M; De Brabander M
    Mykosen; 1981 Oct; 24(10):596-602. PubMed ID: 6270550
    [No Abstract]   [Full Text] [Related]  

  • 3. Modified response to ketoconazole of Candida albicans from a treatment failure.
    Warnock DW; Johnson EM; Richardson MD; Vickers CF
    Lancet; 1983 Mar; 1(8325):642-3. PubMed ID: 6131314
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of pH on ketoconazole activity against Candida parapsilosis and Candida albicans.
    Beggs WH
    Res Commun Chem Pathol Pharmacol; 1982 Sep; 37(3):495-8. PubMed ID: 6294764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined activity of ketoconazole and sulphamethoxazole against Candida albicans.
    Beggs WH
    J Antimicrob Chemother; 1982 Dec; 10(6):539-41. PubMed ID: 6298174
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of ketoconazole on the initial stages of germ tube formation by strains of Candida albicans.
    Johnson EM; Barnard ML; Richardson MD; Warnock DW
    Mykosen; 1982 Sep; 25(9):481-6. PubMed ID: 6292712
    [No Abstract]   [Full Text] [Related]  

  • 7. Ketoconazole resistance.
    Lancet; 1982 Oct; 2(8301):770-1. PubMed ID: 6125840
    [No Abstract]   [Full Text] [Related]  

  • 8. Fungistatic effects of optical brightener 220 against Trichophyton tonsurans, Aspergillus fumigatus and Candida albicans.
    Sadeghi G; Khaksar AA; Bassiri Jahromi S; Amirkhani A; Eslamifar A; Ajdary S; Katiraee F; Taeb J; Paskiabi FA; Sayyah M
    J Dermatolog Treat; 2009; 20(2):120-3. PubMed ID: 19003591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pH on the activity of ketoconazole against Candida albicans.
    Minagawa H; Kitaura K; Nakamizo N
    Antimicrob Agents Chemother; 1983 Jan; 23(1):105-7. PubMed ID: 6299178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The activity in vitro and in vivo of a new imidazole antifungal, ketoconazole.
    Odds FC; Milne LJ; Gentles JC; Ball EH
    J Antimicrob Chemother; 1980 Jan; 6(1):97-104. PubMed ID: 6244258
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of ketoconazole on the fungicidal action of amphotericin B in Candida albicans.
    Sud IJ; Feingold DS
    Antimicrob Agents Chemother; 1983 Jan; 23(1):185-7. PubMed ID: 6299182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro synergism between nyasol, an active compound isolated from Anemarrhena asphodeloides, and azole agents against Candida albicans.
    Iida Y; Oh KB; Saito M; Matsuoka H; Kurata H
    Planta Med; 2000 Jun; 66(5):435-8. PubMed ID: 10909263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antifungal activity of posaconazole against various pathogenic fungi.
    Uchida K; Yokota N; Yamaguchi H
    Int J Antimicrob Agents; 2001 Aug; 18(2):167-72. PubMed ID: 11516940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of zygomycetes to amphotericin B, miconazole, and ketoconazole.
    Eng RH; Person A; Mangura C; Chmel H; Corrado M
    Antimicrob Agents Chemother; 1981 Nov; 20(5):688-90. PubMed ID: 6275783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activity of ketoconazole in mixed cultures of leukocytes and Candida albicans.
    de Brabander M; Aerts F; van Cutsem J; van den Bossche H; Borgers M
    Sabouraudia; 1980 Sep; 18(3):197-210. PubMed ID: 6254187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungi.
    Wiederhold NP; Patterson TF; Srinivasan A; Chaturvedi AK; Fothergill AW; Wormley FL; Ramasubramanian AK; Lopez-Ribot JL
    Virulence; 2017 Feb; 8(2):138-142. PubMed ID: 27268469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility studies with oxiconazole (Ro 13-8996).
    Gebhart RJ; Espinel-Ingroff A; Shadomy S
    Chemotherapy; 1984; 30(4):244-7. PubMed ID: 6086246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endophytic fungi from Ginkgo biloba and their biological activities].
    Yu H; Zhang L; Li L; Li W; Han T; Guo L; Qin L
    Zhongguo Zhong Yao Za Zhi; 2010 Aug; 35(16):2133-7. PubMed ID: 21046747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antifungal resistance in opportunistic pathogenic fungi (II). Imidazoles and triazoles].
    Martínez-Suárez JV; Rodríguez-Tudela JL
    Enferm Infecc Microbiol Clin; 1996 Oct; 14(8):490-8. PubMed ID: 9011208
    [No Abstract]   [Full Text] [Related]  

  • 20. Propyl gallate increases in vitro antifungal imidazole activity against Candida albicans.
    Strippoli V; Dauria FD; Tecca M; Callari A; Simonetti G
    Int J Antimicrob Agents; 2000 Sep; 16(1):73-6. PubMed ID: 11185418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.